Neurotron Biotechnology
Hangzhou
About Neurotron Biotechnology
Nurotron Biotechnology is a medical device company that designs, develops and markets neurostimulation systems. The company’s flagship product is the Venus Cochlear Implant System. Nurotron’s patent portfolio also includes an auditory brainstem implant, artificial retina system, and systems to treat paralysis due to stroke. Founded in 2006, Nurotron maintains its research and development center in Irvine, Calif., and manufacturing facilities in Hangzhou, China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $16.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Dec 2013)
- Website: nurotronus.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical Device
Canonical: https://fsome.com/organization/neurotron-biotechnology-2889501 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.